本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Teladoc Health Inc.

8.04
+0.16502.10%
成交量:95.48萬
成交額:765.67萬
市值:14.20億
市盈率:-6.73
高:8.07
開:7.89
低:7.86
收:7.87
52周最高:15.21
52周最低:6.35
股本:1.77億
流通股本:1.75億
量比:1.87
換手率:0.55%
股息:- -
股息率:- -
每股收益(TTM):-1.1945
每股收益(LYR):-5.8702
淨資產收益率:-14.18%
總資產收益率:-3.57%
市淨率:1.00
市盈率(LYR):-1.37

資料載入中...

2025/09/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/09/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/09/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/09/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/09/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/09/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/09/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/07/30

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/07/29

重要事件披露

Form 8-K - Current report
2025/07/24

重要事件披露

Form 8-K - Current report
2025/06/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/06/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/06/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/06/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/06/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/06/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/05/23

重要事件披露

Form 8-K - Current report
2025/05/01

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/01

重要事件披露

Form 8-K - Current report
2025/04/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities